P288 Copd patients with varying severity of airflow limitation achieve highest peak inspiratory flow rate via the breezhaler® inhaler compared to the ellipta® or the handihaler® dry powder inhalers
Goyal, P, Wehbe, L, Dederichs, J, Guerin, T, Moronta, MC, Pino, AV, Kostikas, K, Altman, PVolume:
71
Language:
english
Journal:
Thorax
DOI:
10.1136/thoraxjnl-2016-209333.431
Date:
December, 2016
File:
PDF, 438 KB
english, 2016